Silverfin false false 31/03/2025 31/03/2025 01/04/2024 no description of principal activity Dr David John Heal 03/06/2019 Dr Sharon Lesley Smith 29/10/2019 12028847 2025-03-31 12028847 bus:Director1 2025-03-31 12028847 bus:Director2 2025-03-31 12028847 2024-03-31 12028847 core:CurrentFinancialInstruments 2025-03-31 12028847 core:CurrentFinancialInstruments 2024-03-31 12028847 2024-04-01 2025-03-31 12028847 bus:Micro-entities 2024-04-01 2025-03-31 12028847 bus:FilletedAccounts 2024-04-01 2025-03-31 12028847 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12028847 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12028847 bus:Director1 2024-04-01 2025-03-31 12028847 bus:Director2 2024-04-01 2025-03-31 12028847 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Company No: 12028847 (England and Wales)

DEVELRX LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

DEVELRX LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 March 2025

Contents

DEVELRX LIMITED

COMPANY INFORMATION

For the financial year ended 31 March 2025
DEVELRX LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 March 2025
DIRECTORS Dr David John Heal
Dr Sharon Lesley Smith
REGISTERED OFFICE 17 Queens Lane
Newcastle Upon Tyne
NE1 1RN
United Kingdom
COMPANY NUMBER 12028847 (England and Wales)
ACCOUNTANT S&W Partners Newcastle Limited
17 Queens Lane
Newcastle
NE1 1RN
DEVELRX LIMITED

BALANCE SHEET

As at 31 March 2025
DEVELRX LIMITED

BALANCE SHEET (continued)

For the financial year ended 31 March 2025
2025 2024
£ £
Fixed assets 1,173 2,672
Current assets 1,135,479 903,260
Prepayments and accrued income 66,635 56,642
Creditors: amounts falling due within one year ( 45,429) ( 30,198)
Net current assets 1,156,685 929,704
Total assets less current liabilities 1,157,858 932,376
Accruals and deferred income ( 60,000) ( 43,000)
Net assets 1,097,858 889,376
Capital and reserves 1,097,858 889,376

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of DevelRX Limited (registered number: 12028847) were approved and authorised for issue by the Board of Directors on 17 December 2025 and were signed on its behalf by:

Dr David John Heal
Director
DEVELRX LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
DEVELRX LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 March 2025

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 12028847). The address of its registered office is 17 Queens Lane, Newcastle Upon Tyne, NE1 1RN, United Kingdom.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 4 3